Cited by 25Substance Abuse Treatment and OutcomesOpioid Use Disorder TreatmentPharmaceutical Practices and Patient Outcomes

Benzodiazepine dependence in subjects with alcohol use disorders: what prevalence?

Morel, A., Grall-Bronnec, M., Bulteau, S., Chauvin-Grelier, P., Gailledrat, L., Pinot, M. L., Jolliet, P., Victorri-Vigneau, C.·2016·Expert Opinion on Drug Safety

Abstract

OBJECTIVE: To our knowledge, no studies have been conducted in France on benzodiazepine (BZD) dependence among outpatients with alcohol use disorders (AUD). Some international studies have been conducted on the consumption of BZD in this specific population, but the comparisons among them are difficult. We aimed to assess the current prevalence of probable benzodiazepine and BZD-like hypnotics (Z-drugs) dependence among outpatients seeking treatment for AUD. METHODS: Participants were patients seeking treatment for AUD for the first time or repeating treatment after more than twelve months. Recruitment took place in seven addiction centres between January and December 2013 in the Nantes region (France). BZD/Z-drug dependence was assessed according to the DSM-IV diagnostic criteria for dependence. This information was gathered through a self-report questionnaire. RESULTS: Among the 1005 patients included in this study, 413 were BZD/Z-drug users (41.1%). Among the 413 patients, 217 were probably dependent on at least one substance, which represents 21.6% of the total population and 52.5% of BZD/Z-drug users. CONCLUSION: BZD/Z-drug dependence represents a public health concern. Prescribers should take the risks into account and keep treatment courses to a minimum.

Integrity signals

Registry

Crossref · 10.1080/14740338.2016.1221922

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Morel, A., Grall-Bronnec, M., Bulteau, S., Chauvin-Grelier, P., Gailledrat, L., Pinot, M. L., Jolliet, P., & Victorri-Vigneau, C.
Affiliations
  • Centre Hospitalier Universitaire de Nantes (FR)
  • EA4275, Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Sciences, University of Nantes, Nantes, France
  • Addictology Department, Les Apsyades association, Bouguenais, France
  • Center for Evaluation and Information on Pharmacodependence, Department of Clinical Pharmacology, University Hospital, Nantes, France
Corresponding author
Morel, A.
Venue
Expert Opinion on Drug Safety
Published
2016-08-22
Volume
15
Issue
10
Pages
1313-1319
ISSN
  • 1474-0338 (ISSN-L)
  • 1744-764X
OpenAlex
W2481097774
Cited by
25
References
22
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 1 · 2021: 5 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 1 · 2014: 1
FWCI
2.81
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
benzodiazepine dependence, alcoholism, Z-drugs, hypnotics, prevalence, comorbidities, outpatients, addiction treatment, benzodiazepine prescribing
MeSH terms
Adult, Ambulatory Care, Benzodiazepines, Cross-Sectional Studies, Female, France, Humans, Male, Middle Aged, Surveys and Questionnaires, Prevalence, Substance Abuse Treatment Centers, Substance-Related Disorders, Alcohol-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review